Ulrike Koehl, MD, PhD, University of Leipzig, Leipzig, Germany, outlines strategies to reduce the costs associated with chimeric antigen receptor T-cell (CAR-T) manufacturing. This includes implementing digitalization and automation and using non-viral transduction protocols. This interview took place at the EBMT-EHA 4th European CAR T-cell Meeting which was held virtually in 2022.